Advanced Rectal Cancer Current Events | Advanced Rectal Cancer News | 5
|
| Page
5 of
105 |
2089 Results |
|
|
|
Sort By:
Page Views | Date |
International study supports new standard of treatment for women with advanced ovarian cancer
Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treating advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course. view more (2008-12-04)
STUDY LOOKS AT NEEDS OF THOSE ON "DISEASE JOURNEYS"
Member of the research team Dr Scott Murray of the University of Edinburgh's Department of Community Health Sciences said the disease 'journeys' of 25 families with lung cancer and 25 with severe cardiac failure would be followed, through interviews with patients, their relatives and professionals from health and social services. The patients and... view more... (1999-06-21)
Potential prostate cancer treatment improvements discovered by researchers at Cedars-Sinai
In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer. view more (2006-03-22)
Dietary calcium could possibly prevent the spread of breast cancer to bone
A strong skeleton is less likely to be penetrated by metastasizing cancer cells, so a fortified glass of milk might be the way to block cancer's spread. view more (2007-10-03)
Experimental chemotherapy regimen shows promise in treating advanced lung cancer
A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. view more (2008-08-12)
Advanced life support in ambulances doesn't benefit trauma patients
New research from the Ontario Prehospital Advanced Life Support (OPALS) project shows there is no benefit - and perhaps harm - to providing advanced life support to patients with trauma injuries prior to transport to hospital. view more (2008-04-22)
Nexavar shown to significantly extend survival for patients with advanced liver cancer
Bayer Pharmaceuticals Corporation (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that an independent data monitoring committee (DMC) has reviewed the safety and efficacy data from the companies' pivotal Phase 3 trial in patients with advanced hepatocellular carcinoma (HCC), or primary liver cancer. view more (2007-02-13)
Cancer-obesity link discovery by MSU researchers could aid prevention efforts
A new link between body fat and cancer identified by a Michigan State University researcher underscores obesity's health risk and could lead to new cancer treatment and prevention strategies. view more (2009-05-01)
Anti-tumor therapy with endoscopic ultrasound may fight cancer more safely and effectively
The chairman of EUS2008 today announced that investigational research on a therapeutic technique that will allow physicians to directly inject malignant tumors with cancer fighting agents from inside the body will be presented at the 16th International Symposium of Endoscopic Ultrasonography (EUS2008) in San Francisco on September 12-13. view more (2008-09-12)
The fight against colorectal cancer
In 2007, colorectal cancer will kill approximately 8700 Canadians. To draw attention to this situation, Dr. Alan Barkun, Director of the gastroenterology department at the McGill University Health Centre (MUHC) and Dr. Ken Flegel, service chief in internal medicine, have coauthored an editorial that will appear in the September 11, 2007 issue of... view more... (2007-09-11)
Mayo Clinic study points to a possible biomarker for colon cancer in people 50 and under
An abnormality of chromosomes long associated with diseases of aging has, for the first time, been linked to colon cancer in people 50 years old and younger, an age group usually considered young for this disease. view more (2007-10-29)
New study shows that a cough medicine ingredient could effectively treat prostate cancer
A study published today in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer. view more (2008-12-19)
Cetuximab with radiotherapy does not increase side effects for head and neck cancer patients
The addition of Cetuximab (brand name Erbitux) to radiation therapy treatments does not increase the rate or duration of some side effects in the treatment of advanced head and neck cancers. view more (2007-01-19)
Cancer Research UK supports additional TroVax phase II trial in colorectal cancer
Oxford BioMedica announced today that Cancer Research UK (CRUK) has agreed to conduct and sponsor an open label Phase II trial with Oxford BioMedica's leading cancer immunotherapy product, TroVax®, in colorectal cancer patients who have liver metastases. The decision by CRUK follows extensive review of the successful Phase I/II data of TroVax... view more... (2003-08-28)
Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percent
Patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail is used, new research finds. They also experience slower disease progression and an increased chance of tumour shrinkage. view more (2009-09-22)
New gene silencing therapy for cervical cancer
Researchers at The University of Queensland's (UQ) Centre for Immunology and Cancer Research (CICR), based at the Princess Alexandra Hospital, have pioneered a new approach for the treatment of cervical cancer. view more (2005-11-17)
Chemo-radiation before prostate removal may prevent cancer recurrence
Researchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient survival. view more (2009-11-05)
OHSU Cancer Institute research gives hope for chemo holidays for men with advanced prostate cancer
Oregon Health & Science University Cancer Institute researchers, in a first-of-its-kind study, have found that even men with advanced prostate cancer can take a much-needed safe break, or holiday, from chemotherapy. view more (2008-02-26)
Is late diagnosis of lung cancer inevitable?
A study by researchers into the diagnosis of patients with lung cancer suggests that avoidable patient delays in reporting symptoms of the disease is an important factor in its treatment. view more (2005-03-23)
Treatment method improves survival for advanced laryngeal cancer, U-M study finds
Chemotherapy and radiation can be effective at treating cancer of the larynx, or voice box, without removing the organ that controls speech and swallowing. But it doesn't work for everyone. view more (2006-02-01)
|
|
| Page
5 of
105 |
2089 Results |
|
|
|
Sort By:
Page Views | Date |
|
